Data / Form D filings / MenoGeniX, Inc.
MenoGeniX, Inc.: Form D filings
MenoGeniX, Inc., a biotechnology company in Aurora, CO, filed 4 Form D notices with the SEC between 2012 and 2017. The latest, on December 14, 2017, reports $75,000 sold of a $200,000 offering to 4 investors.
Find out what MenoGeniX, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12635 EAST MONTVIEW BLVD., SUITE 100, Aurora, CO, 80045
- Phone
- (720) 859-4100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Colorado
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1555128
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 14, 2017 | New notice | $200,000 | $75,000 | $125,000 | 4 | Nov 30, 2017 | sec.gov |
| Sep 2, 2016 | New notice | $200,000 | $200,000 | $0 | 14 | Aug 18, 2016 | sec.gov |
| Aug 8, 2014 | New notice | $500,000 | $405,000 | $95,000 | 15 | Jul 30, 2014 | sec.gov |
| Jul 31, 2012 | New notice | $500,000 | $500,000 | $0 | 20 | Jul 25, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Debra M. Duke | Executive Officer | |
| Richard C. Duke | Executive Officer, Director | |
| James Woodruff Emlen | Director | |
| T. Richard Fort | Director |
Other biotechnology companies in Colorado that filed recently
- HealthVest Fund V LLC offering · Nov 5, 2026
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
Every Form D from the week of Dec 11, 2017 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MenoGeniX, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.